Menu Search
Equities

OrthoPediatrics Corp

2X7:DEU

OrthoPediatrics Corp

Actions
  • Price (EUR)22.80
  • Today's Change0.20 / 0.88%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year OrthoPediatrics Corp had net income fall from a gain of 1.26m to a loss of 20.97m despite a 21.62% increase in revenues from 122.29m to 148.73m.
Gross margin73.68%
Net profit margin-15.00%
Operating margin-17.00%
Return on assets-6.17%
Return on equity-7.63%
Return on investment-6.78%
More ▼

Cash flow in USDView more

In 2023, OrthoPediatrics Corp increased its cash reserves by 215.69%, or 22.57m. Cash Flow from Investing totalled 41.68m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 27.05m for operations while cash generated from financing totalled 7.30m.
Cash flow per share-0.3556
Price/Cash flow per share--
Book value per share15.32
Tangible book value per share8.05
More ▼

Balance sheet in USDView more

OrthoPediatrics Corp appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio7.17
Quick ratio3.68
Total debt/total equity0.1959
Total debt/total capital0.1638
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.